Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

Background Progressive volumetric changes in the brains of people with schizophrenia have been attributed to a number of factors. Aims To determine whether glutamatergic changes in patients with schizophrenia correlated with grey-matter losses during the first years of illness. Method Left anterior cingulate and thalamic glutamatergic metabolite levels and grey-matter volumes were examined in 16 patients with first-episode schizophrenia before and after 10 months and 30 months of antipsychotic treatment and in 16 healthy participants on two occasions 30 months apart. Results Higher than normal glutamine levels were found in the anterior cingulate and thalamus of never-treated patients. Thalamic levels of glutamine were significantly reduced after 30 months. Limited grey-matter reductions were seen in patients at 10 months followed by widespread grey-matter loss at 30 months. Parietal and temporal lobe grey-matter loss was correlated with thalamic glutamine loss. Conclusions Elevated glutamine levels in never-treated patients followed by decreased thalamic glutamine and grey-matter loss in connected regions could indicate either neurodegeneration or a plastic response to reduced subcortical activity.

[1]  R S Menon,et al.  Spectroscopic lineshape correction by QUECC: Combined QUALITY deconvolution and eddy current correction , 2000, Magnetic resonance in medicine.

[2]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[3]  Joel Jeffries,et al.  Clinical Handbook of Psychotropic Drugs , 1994 .

[4]  T. Crow,et al.  Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. , 2005, The American journal of psychiatry.

[5]  N. Andreasen,et al.  Anatomic and Functional Variability: The Effects of Filter Size in Group fMRI Data Analysis , 2001, NeuroImage.

[6]  Joseph R. Sligo,et al.  EMPIRICAL COMPARISON OF UNIVARIATE AND MULTIVARIATE ANALYSIS OF VARIANCE PROCEDURES , 1971 .

[7]  Leif Hertz,et al.  Astrocytes: Glutamate producers for neurons , 1999, Journal of neuroscience research.

[8]  Jeffrey A Lieberman,et al.  Measurement of Brain Metabolites by 1H Magnetic Resonance Spectroscopy in Patients with Schizophrenia: A Systematic Review and Meta-Analysis , 2005, Neuropsychopharmacology.

[9]  Ravi S. Menon,et al.  Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia , 2004, British Journal of Psychiatry.

[10]  Thomas F. Nugent,et al.  Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. , 2004, Archives of general psychiatry.

[11]  Khalid Ali,et al.  Proof , 2006, BMJ : British Medical Journal.

[12]  Jun Yan,et al.  Multiparametric changes in the receptive field of cortical auditory neurons induced by thalamic activation in the mouse. , 2006, Cerebral cortex.

[13]  P. A. Thompson,et al.  Robustness properties of nonorthogonal analysis of variance. , 1987 .

[14]  Karl J. Friston,et al.  Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.

[15]  G. Box NON-NORMALITY AND TESTS ON VARIANCES , 1953 .

[16]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[17]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[18]  P. Williamson Mind, Brain, and Schizophrenia , 2005 .

[19]  J. Lieberman,et al.  Brain volume in first-episode schizophrenia , 2006, British Journal of Psychiatry.

[20]  N. Weinberger Dynamic regulation of receptive fields and maps in the adult sensory cortex. , 1995, Annual Review of Neuroscience.

[21]  A. Grace,et al.  Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. , 1998, Schizophrenia bulletin.

[22]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[23]  J. Stevens Applied Multivariate Statistics for the Social Sciences , 1986 .

[24]  Ravi S. Menon,et al.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.

[25]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[26]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .

[27]  J. Lauriello,et al.  Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. , 2005, The American journal of psychiatry.

[28]  C. Hanstock,et al.  3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. , 2004, The American journal of psychiatry.

[29]  J. Rapoport,et al.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Brooks,et al.  Applied Multivariate Statistics for the Social Sciences , 1993 .

[31]  M. Bryden Measuring handedness with questionnaires , 1977, Neuropsychologia.

[32]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[33]  D J Drost,et al.  Factors affecting the quantification of short echo in‐vivo 1H MR spectra: prior knowledge, peak elimination, and filtering , 1999, NMR in biomedicine.

[34]  G. Box Some Theorems on Quadratic Forms Applied in the Study of Analysis of Variance Problems, I. Effect of Inequality of Variance in the One-Way Classification , 1954 .

[35]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[36]  J. Stevens,et al.  Applied multivariate statistics for the social sciences, 4th ed. , 2002 .

[37]  R W Neufeld,et al.  Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.

[38]  R. Menon,et al.  Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla , 2000, Magnetic resonance in medicine.